Skip to content
VuFind
English
Deutsch
Español
Français
Italiano
日本語
Nederlands
Português
Português (Brasil)
中文(简体)
中文(繁體)
Türkçe
עברית
Gaeilge
Cymraeg
Ελληνικά
Català
Euskara
Русский
Čeština
Suomi
Svenska
polski
Dansk
slovenščina
اللغة العربية
বাংলা
Galego
Tiếng Việt
Hrvatski
हिंदी
Հայերէն
Українська
Sámegiella
Монгол
語言
全文檢索
題名
作者
主題
索引號
ISBN/ISSN
標簽
檢索
高級檢索
Do Diuretics, Beta-Blockers, a...
引用
發送短信
推薦此
打印
導出紀錄
導出到 RefWorks
導出到 EndNoteWeb
導出到 EndNote
Permanent link
Do Diuretics, Beta-Blockers, and Statins Increase the Risk of Diabetes in Patients with Impaired Glucose Tolerance? Insights from the NAVIGATOR Study
書目詳細資料
Main Authors:
Shen, L
,
Shah, B
,
Reyes, E
,
Thomas, L
,
Diem, P
,
Leiter, L
,
Charbonnel, B
,
Mareev, V
,
Horton, E
,
Haffner, S
,
Soska, V
,
Holman, R
,
Bethel, M
,
Schaper, F
,
Sun, J
,
McMurray, J
,
Califf, R
,
Krum, H
格式:
Journal article
出版:
2012
持有資料
實物特徵
相似書籍
職員瀏覽
相似書籍
Role of diuretics, β blockers, and statins in increasing the risk of diabetes in patients with impaired glucose tolerance: reanalysis of data from the NAVIGATOR study.
由: Shen, L, et al.
出版: (2013)
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for hypertension on clinical end points: a cohort study.
由: McMurray, J, et al.
出版: (2012)
Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers for Hypertension on Clinical End Points: A Cohort Study
由: Mcmurray, J, et al.
出版: (2012)
Baseline characteristics of the Nateglinide and Valsartan Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) trial population: comparison with other diabetes prevention trials.
由: Krum, H, et al.
出版: (2010)
Association of non-alcoholic steatothepatitis with components of the metabolic syndrome in 43,509 patients screened for NAVIGATOR
由: Bethel, A, et al.
出版: (2005)